As perhaps the two most powerful health industry lobbyists in Washington, Billy Tauzin and Karen Ignagni illustrates the complexities President Obama faces in the healthcare endgame, the New York Times reports. Tauzin is the chief lobbyist for drug makers, while Ignagni represents insurers. With insurers blaming drug makers for high prices and drug makers blaming insurers for scanty coverage, the two association chiefs have a kind of kind of trust-but-verify relationship, according to the Times.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
